Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Acthrel Market Expected To Reach $ Billion By 2030 At % CAGR
The expansion observed in the historical period was driven by several factors, including the clinical demand for accurate adrenal diagnostics, the well-defined function of HPA testing, the rise of endocrinology subspecialties, the integration of diagnostic tools within hospitals, and official approvals for their application in medical testing.
The projected rise during the forecast period stems from the growing frequency of endocrine disorders, a heightened need for precise diagnostic capabilities, the wider establishment of specialized diagnostic facilities, more extensive clinical research efforts, and the integration of these methods into sophisticated hospital laboratories. Key developments expected in this period encompass broader application of endocrine diagnostic testing, a stronger emphasis on correctly evaluating the HPA axis, the proliferation of dedicated hormonal diagnostics, enhanced clinical distinction for Cushing’s syndrome, and increased utilization in cutting-edge endocrinology centers.
Download A Free Sample Report For Comprehensive Market Insights:
Acthrel Market Industry Drivers: What Is Driving Revenue Growth?
The increasing need for diagnostic testing is anticipated to boost the growth of the acthrel market in the coming period. Diagnostic testing involves medical procedures aimed at detecting or confirming the presence of a disease or condition in a patient. This rise in diagnostic testing is driven by factors like progress in medical technology, a heightened emphasis on early disease identification, greater health awareness, and an aging population. By stimulating the pituitary gland to release adrenocorticotropic hormone (ACTH), Acthrel assists in diagnostic testing, allowing healthcare providers to assess adrenal gland function and diagnose issues such as adrenal insufficiency or disorders linked to the hypothalamic-pituitary-adrenal axis. As an example, in December 2024, data from the National Health Service, a government department in the UK, showed that the number of diagnostic tests performed reached 2,544,809 in 2024, up from 2,312,030 in 2023. Consequently, the growing demand for diagnostic testing is propelling the acthrel market.
Higher healthcare spending is projected to drive the growth of the acthrel markets moving forward. Healthcare expenditure represents the total financial resources allocated to or used for healthcare services and goods over a given timeframe. This increased demand for healthcare expenditure stems from the rising frequency of chronic diseases, which necessitate prolonged and costly treatments. Acthrel plays a role in elevating healthcare spending by facilitating accurate testing of the hypothalamic-pituitary-adrenal (HPA) axis, crucial for diagnosing complex endocrine conditions like adrenal insufficiency and Cushing’s syndrome, thereby fostering greater investment in diagnostic tools, therapeutic approaches, and specialized healthcare services. For illustration, in May 2024, according to the Office for National Statistics, a UK government agency, total healthcare expenditure rose by 5.6% in nominal terms in 2023, marking a 0.9% increase compared to 2022. Thus, the increase in healthcare expenditure is fueling the acthrel market.
A rising occurrence of endocrine diseases is anticipated to fuel the acthrel market in the future. Endocrine diseases are disorders affecting the endocrine glands, resulting in imbalances in hormone production and regulation, which disrupts overall body functions. This increase in endocrine diseases is fueled by unhealthy lifestyle habits, such as poor nutrition, lack of physical activity, and chronic stress, which disturb hormonal balance and raise the likelihood of metabolic and glandular issues. Acthrel aids in the diagnostic assessment of the hypothalamic-pituitary-adrenal (HPA) axis, enabling accurate detection and management of adrenal and related endocrine disorders amid the growing prevalence of these diseases. For example, in June 2024, the National Health Service, a UK government department, reported that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels not reaching diabetes thresholds) in 2023, an 18% rise from 3,065,825 cases in 2022. Therefore, the increasing incidence of endocrine diseases is propelling the acthrel market.
Acthrel Market Segments: Where Are The Largest Growth Opportunities?
The acthrel market covered in this report is segmented –
1) By Application: Diagnosis Of Adrenal Insufficiency, Hypothalamic-Pituitary-Adrenal (HPA) Axis Testing, Medical Research
2) By End User: Adult, Geriatric
3) By Distribution Channel: Hospital And Clinics, Retail And Specialty Pharmacies
Acthrel Market Major Participants And Competitive Dynamics
Major companies operating in the acthrel market are Ferring Pharmaceuticals
Access The Complete Acthrel Market Report:
Acthrel Market Regional Analysis And Leading Geography
North America was the largest region in the acthrel market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acthrel market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model